Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) has a beta value of 0.05 and has seen 5.43 million shares traded in the last trading session. The company, currently valued at $28.92M, closed the last trade at $0.62 per share which meant it lost -$0.33 on the day or -34.91% during that session. The RVPH stock price is -590.32% off its 52-week high price of $4.28 and 3.23% above the 52-week low of $0.60. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.0 million shares traded. The 3-month trading volume is 1.47 million shares.
The consensus among analysts is that Reviva Pharmaceuticals Holdings Inc (RVPH) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.19.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) trade information
Sporting -34.91% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the RVPH stock price touched $0.62 or saw a rise of 47.01%. Year-to-date, Reviva Pharmaceuticals Holdings Inc shares have moved -65.70%, while the 5-day performance has seen it change -45.06%. Over the past 30 days, the shares of Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) have changed -51.50%. Short interest in the company has seen 2.85 million shares shorted with days to cover at 2.57.
Reviva Pharmaceuticals Holdings Inc (RVPH) estimates and forecasts
The company’s shares have lost -54.01% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
Earnings growth for 2025 is a modest 20.56% while over the next 5 years, the company’s earnings are expected to increase by 29.90%.
RVPH Dividends
Reviva Pharmaceuticals Holdings Inc is expected to release its next earnings report on 2025-Mar-30 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s Major holders
Insiders own 14.30% of the company shares, while shares held by institutions stand at 29.49% with a share float percentage of 34.41%. Investors are also buoyed by the number of investors in a company, with Reviva Pharmaceuticals Holdings Inc having a total of 47.0 institutions that hold shares in the company. The top two institutional holders are WOODLINE PARTNERS LP with over 1.59 million shares worth more than $2.04 million. As of 2024-06-30, WOODLINE PARTNERS LP held 5.2129% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 1.03 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.31 million and represent 4.2659% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 2.78% shares in the company for having 930.44 shares of worth $0.58 million while later fund manager owns 312.3 shares of worth $0.19 million as of Dec 31, 2024 , which makes it owner of about 0.93% of company’s outstanding stock.
